These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12409032)

  • 1. Call to tackle sepsis.
    Bosch X
    Lancet Infect Dis; 2002 Nov; 2(11):649. PubMed ID: 12409032
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost evaluation of patients with severe sepsis in intensive care units.
    Piacevoli Q; Palazzo F; Azzeri F
    Minerva Anestesiol; 2004 Jun; 70(6):453-71. PubMed ID: 15235553
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating the clinical and financial impact of severe sepsis with Medicare or other administrative hospital data.
    Ernst FR; Malatestinic WN; Linde-Zwirble WT
    Am J Health Syst Pharm; 2006 Mar; 63(6):575-81. PubMed ID: 16522894
    [No Abstract]   [Full Text] [Related]  

  • 4. Economics and outcome in the intensive care unit.
    Pittoni GM; Scatto A
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):232-6. PubMed ID: 19390250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic healthcare expenditure in survivors of sepsis in the intensive care unit.
    Koster-Brouwer ME; van de Groep K; Pasma W; Smeets HM; Slooter AJC; de Lange DW; van Dijk D; van der Poll T; Bonten MJM; Cremer OL;
    Intensive Care Med; 2016 Oct; 42(10):1641-1642. PubMed ID: 27395005
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.
    Burchardi H; Schneider H
    Pharmacoeconomics; 2004; 22(12):793-813. PubMed ID: 15294012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis.
    Brun-Buisson C; Roudot-Thoraval F; Girou E; Grenier-Sennelier C; Durand-Zaleski I
    Intensive Care Med; 2003 Sep; 29(9):1464-71. PubMed ID: 12856120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost differences in the treatment of severe sepsis between survivors and non-survivors on the first day of intensive care admission].
    Csomós A; Szentkereszty Z; Fülesdi B
    Orv Hetil; 2007 Sep; 148(39):1851-6. PubMed ID: 17890173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The incidence and cost of severe sepsis in intensive care units].
    Csomós A; Hoffer G; Fülesdi B; Ludwig E
    Orv Hetil; 2005 Jul; 146(29):1543-7. PubMed ID: 16136776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Society of Intensive Care Medicine (ESICM) and the Surviving Sepsis Campaign (SSC).
    Ranieri VM; Moreno RP; Rhodes A;
    Intensive Care Med; 2007 Mar; 33(3):423-5. PubMed ID: 17325835
    [No Abstract]   [Full Text] [Related]  

  • 11. The economic burden of sepsis in Austria.
    Schmid A; Schneider H
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):1023-4; author reply 1024. PubMed ID: 12635473
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of HIV/AIDS on care and outcomes of severe sepsis.
    Mrus JM; Braun L; Yi MS; Linde-Zwirble WT; Johnston JA
    Crit Care; 2005; 9(6):R623-30. PubMed ID: 16280060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost analysis of Omega-3 supplementation in critically ill patients with sepsis.
    Kyeremanteng K; Shen J; Thavorn K; Fernando SM; Herritt B; Chaudhuri D; Tanuseputro P
    Clin Nutr ESPEN; 2018 Jun; 25():63-67. PubMed ID: 29779820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?
    Shorr AF; Micek ST; Jackson WL; Kollef MH
    Crit Care Med; 2007 May; 35(5):1257-62. PubMed ID: 17414080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From A&E to ICU: how nurses can support the Surviving Sepsis Campaign.
    Robson WP
    Intensive Crit Care Nurs; 2004 Jun; 20(3):113-5. PubMed ID: 15157929
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of severity of illness on resource use by survivors and nonsurvivors of severe sepsis at intensive care unit admission.
    Teres D; Rapoport J; Lemeshow S; Kim S; Akhras K
    Crit Care Med; 2002 Nov; 30(11):2413-9. PubMed ID: 12441747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calculation of costs per inpatient day in an intensive care unit].
    Alvear V S; Canteros J; Rodríguez P
    Rev Med Chil; 2010 May; 138(5):558-66. PubMed ID: 20668810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit.
    Edbrooke DL; Hibbert CL; Kingsley JM; Smith S; Bright NM; Quinn JM
    Crit Care Med; 1999 Sep; 27(9):1760-7. PubMed ID: 10507595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of drotrecogin alfa (activated).
    Tsitanidis J
    Crit Care Med; 2003 Sep; 31(9):2414-5; author reply 2415. PubMed ID: 14501983
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacist on intensive care unit saves lives and reduces costs.
    Knibbe CA; Tjoeng MM
    Crit Care Med; 2008 Dec; 36(12):3269-70. PubMed ID: 19020439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.